| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |